The 6th Annual Diabetes Today and Tomorrow Conference: May 18, 2013
Presented in Partnership with
More than 1,000 people with insulin-dependent (T1) and insulin-requiring (T2) diabetes, their family members and medical care professionals will gather to hear the latest in leading-edge research, treatment advances and care strategies from a collection of internationally recognized experts. This year's conference will take place at a new venue: the Wayne County Community College District - Western Campus (map).
All online registration for the Diabetes Today and Tomorrow Conference and Exhibits is now closed. Please email Denise Pentescu at dpentescu@jdrf.org to inquire if space is still available, including your name, address and phone number in your correspondence. We will notify you as soon as possible about attending.
Team JDRF Challenge Events
Now recruiting participants!
Let your passion for helping others provide the inspiration to train and raise money to cure type 1 diabetes. For more information about JDRF Challenge Events or to participate in the endurance event of your choice, click the Take the Challenge banner above.
Run or Walk: Team JDRF Challenge
Together with your local teammates, train to run or walk a marathon or 1/2 marathon with JDRF’s expert coaches.
First Single Gene Mutation Shown to Result in Type 1 Diabetes
A JDRF-funded study out of Switzerland has shown that a single gene called SIRT1 may be involved in the development of type 1 diabetes (T1D) and other autoimmune diseases. The study, “Identification of a SIRT1 Mutation in a Family with Type 1 Diabetes,” was published today in Cell Metabolism and represents the first demonstration of a monogenetic defect leading to the onset of T1D. Read more here.
JDRF Comments on Economic Impact of Diabetes
Health economists funded by the American Diabetes Association released an update today of their analysis of the costs of diabetes in the United States, noting an increase in cost of 41 percent, from $174 billion in 2007 to $245 billion in 2012. The analysis points to the rise in diabetes as a catalyst for this alarming increase. Both type 1 and type 2 diabetes are rising.
In 2012, JDRF released a study showing that therapies to improve glucose control could save the Medicare program $190 billion over the course of 25 years. Research to cure, treat, and prevent diabetes is not only needed for those living with T1D; it is also pertinent to the long-term fiscal health of our country.
Exciting News About the Artificial Pancreas Project
Tom Brobson, who is the JDRF National Director of Research Investment Opportunities and was diagnosed with T1D at 44, recently spent three days and two nights in a clinical trial of the artificial pancreas system. While out to dinner, over night and through an ice cream sundae, a sophisticated smartphone took data from a continuous glucose sensor and helped to automate delivery from Tom’s insulin pump. Learn more, directly from Tom, in the video below.
